 Telegraph.co.uk | Breakthrough breast cancer drug 'too expensive' Telegraph.co.uk At that stage, chemotherapy is usually the only option. Last September early trial results were published showing that when combined with chemo, everolimus could more than double the time tumours were 'stalled', compared to chemo alone. The respective ... Breast cancer drug does not provide value for money, regulator rules UK cost body rejects Novartis breast cancer drug |
